A New Type 2 Diabetes Microsimulation Model to Estimate Long-Term Health Outcomes, Costs, and Cost-Effectiveness

This study aimed to develop a microsimulation model to estimate the health effects, costs, and cost-effectiveness of public health and clinical interventions for preventing/managing type 2 diabetes. We combined newly developed equations for complications, mortality, risk factor progression, patient...

Celý popis

Uložené v:

Podrobná bibliografia
Vydané v:	Value in health Ročník 26; číslo 9; s. 1372 - 1380
Hlavní autori:	Hoerger, Thomas J., Hilscher, Rainer, Neuwahl, Simon, Kaufmann, Matthew B., Shao, Hui, Laxy, Michael, Cheng, Yiling J., Benoit, Stephen, Chen, Haiying, Anderson, Andrea, Craven, Tim, Yang, Wenya, Cintina, Inna, Staimez, Lisa, Zhang, Ping
Médium:	Journal Article
Jazyk:	English
Vydavateľské údaje:	United States Elsevier Inc 01.09.2023
Predmet:	Adult Cost-Benefit Analysis diabetes Diabetes Mellitus, Type 2 - complications Diabetes Mellitus, Type 2 - epidemiology Diabetes Mellitus, Type 2 - therapy Glycated Hemoglobin Humans Internal Medicine microsimulation Middle Aged Outcome Assessment, Health Care probabilistic sensitivity analysis Public Health Quality-Adjusted Life Years risk equations United States - epidemiology United States probabilistic sensitivity analysis risk equations diabetes microsimulation
ISSN:	1098-3015, 1524-4733, 1524-4733
On-line prístup:	Získať plný text
Tagy:	Pridať tag Žiadne tagy, Buďte prvý, kto otaguje tento záznam!

Buďte prvý, kto okomentuje tento záznam!